expression. Finally, we identified reduced AP1 and CRE activity, analysed by reporter geneand electrophoretic mobility shift assays, important for redundancy mechanism which rescued delayed hypertrophic differentiation and allows normal development of MIA À/À mice. In summary, as observed in other knockout models of molecules important for cartilage development and differentiation, viability and functional integrity is reached by remarkable molecular redundancy in MIA/CD-RAP knockout mice.
Introduction
MIA/CD-RAP (melanoma inhibitory activity/cartilagederived retinoic acid-sensitive protein) was purified as a growth regulating and secreted protein in human melanoma cell lines (Blesch et al., 1994; van Groningen et al., 1995) . Independent analysis, comparing differentiated with dedifferentiated chondrocytes, also identified MIA/CD-RAP in cartilage (Dietz and Sandell, 1996) . In situ hybridization of mouse embryos revealed MIA/CD-RAP expression starting at the beginning of chondrogenesis and abundant expression throughout cartilage development (Bosserhoff et al., 1997; Dietz and Sandell, 1996) . The MIA/CD-RAP expression correlates tightly with the expression of cartilage specific collagen type II (Dietz and Sandell, 1996) . Differentiation of human mesenchymal stem cells and re-differentiation of primary chondrocytes showed co-expression of MIA/CD-RAP with the major cartilage component aggrecan (Onoue et al., 2011) . In vivo experiments, using transgenic mice in which the lacZ-reporter gene was under the control of the MIA/CD-RAP promoter, showed restricted expression of the reporter gene in developing chondrocytes and in mature cartilage (Xie et al., 2000) . Together with in vitro analysis of primary chondrocytes confirming MIA/CD-RAP expression with the 0925-4773/$ -see front matter Ó 2013 Elsevier Ireland Ltd. All rights reserved. http://dx.doi.org/10.1016/j.mod.2013.11.001 beginning of differentiation, MIA/CD-RAP was revealed to be a specific marker for chondrocyte differentiation (Bosserhoff and Buettner, 2003) .
To study the consequences of MIA/CD-RAP deficiency in vivo we generated MIA/CD-RAP-deficient (MIA À/À ) mice (Moser et al., 2002) . Recent expression analysis of cartilage tissue derived from MIA À/À mice revealed strong downregulation of p54 nrb (54 kDa nuclear RNA-and DNA-binding protein) (Schmid et al., 2010) . We were able to show that p54 nrb acts as a mediator of MIA/CD-RAP action to promote chondrogenesis through inhibition of proliferation by negative cell cycle regulation via Cyclin D2 and through induction of differentiation via activation of the COL2A1 promoter (Schmid et al., 2010) . These data suggest functional importance of MIA/CD-RAP in chondrocyte differentiation. However, MIA À/À mice are viable, develop normally and show no major abnormalities of cartilage by means of light microscopy (Moser et al., 2002) . First data gained from analysis of MIA À/À mice indicate that MIA/CD-RAP function is required for the highly ordered fibrillar ultra structure of cartilage. Electron microscopic analyses reveal defects in collagen fiber density, diameter and arrangement as well as changes in the number and morphology of chondrocytic microvilli (Moser et al., 2002) .
In this study, we analysed molecular changes during embryogenesis to uncover potential redundancy mechanisms in vivo, which explain the surprisingly normal phenotype in adult MIA/CD-RAP-deficient mice, although a role of MIA/ CD-RAP in chondrogenesis has been demonstrated.
Results
Recent studies in our group uncovered a surprisingly intense phenotype in MIA À/À mice characterized by enhanced regenerative cartilage potential. Moreover, we revealed enhanced proliferation and delayed differentiation in mesenchymal stem cells derived from MIA À/À mice (Schmid et al., 2010) . However, MIA À/À mice are viable, develop normally, and show only a slight phenotype characterized by ultrastructural abnormalities of the cartilage (Moser et al., 2002) . Since a role of MIA/CD-RAP in chondrogenesis has been demonstrated, we expected early redundancy mechanisms which immediately counteract loss of MIA/CD-RAP in cartilage development and explain the almost normal development despite MIA/CD-RAP-loss. We therefore focused on endochondral ossification of the femur during embryogenesis to determine molecular changes in addition to lack of MIA/CD-RAP. (Dessau et al., 1980; Nah et al., 1988) , Col10a1 (Mueller and Tuan, 2008; Shen, 2005) and Sox9 (Wright et al., 1995) , important markers for chondrogenesis and endochondral ossification, was investigated by in situ hybridisation. Col2a1 and Sox9 (Akiyama et al., 2002; Zhao et al., 1997) are expressed in proliferating differentiated chondrocytes of the growth plate, whereas Col10a1 expression is restricted to postmitotic hypertrophic chondrocytes (Schmid and Linsenmayer, 1985) .
The femur of 14.5, 15.5 and 16.5 dpc old WT and MIA To analyse whether these differences in chondrogenesis had effects on bone length, we determined the size of the femur of WT and MIA À/À embryos. Femur length did not differ at day 14.5, 15.5 and 16.5 dpc of embryogenesis between WT and MIA À/À mice (Fig. 2D ).
2.2.
Expression of transcription factors important for hypertrophic differentiation are not altered by loss of MIA/ CD-RAP These initial findings revealed changes in early stages of endochondral ossification, specifically in the transition from proliferating Col2a1 and Sox9 positive chondrocytes to hypertrophic Col10a1 expressing cells indicated by an enhanced area of proliferating chondrocytes. To specify this effect, we performed in vitro experiments with differentiated murine mesenchymal stem cells (mMSC). We first examined possible direct effects of MIA/CD-RAP loss on hypertrophic differentiation. For this purpose we analysed the mRNA expression of the transcription factors Ap-2e and Runx2 in differentiated mMSC derived from WT and MIA À/À mice. Ap-2e (Wenke et al., 2009 ) and Runx2 (Enomoto et al., 2000; Stricker et al., 2002) are important regulators of hypertrophy in chondrocytes. Ap-2e and Runx2 mRNA expression did not differ between WT and MIA À/À lots ( Fig. 3A and B). As there was no difference in expression of transcription factors essential for hypertrophic differentiation, we focused on transcription factors directly regulating the transition from proliferating to hypertrophic chondrocytes.
2.3.
Sox9, Sox6 and Ap-2a expression was upregulated in MIA À/À murine mesenchymal stem cells
Sox9 and Sox6 are known to maintain proliferation of chondrocytes of the growth plate and prevent terminal differentiation of proliferating chondrocytes to hypertrophic chondrocytes (Akiyama et al., 2002; Amano et al., 2009; Smits et al., 2004; Zhou et al., 2006) . Analysis of Sox9 mRNA levels confirmed induced Sox9 expression in MIA À/À mMSC compared to WT mMSC. Interestingly Sox6 mRNA expression was also elevated in mMSC derived from MIA À/À mice ( Fig. 4A and B).
We further examined the expression of the transcription factor Ap-2a, also know to play important roles in endochondral ossification (Huang et al., 2004) . Ap-2a mRNA expression was elevated in MIA À/À mMSC as well (Fig. 4C ). As previously shown (Schmid et al., 2010) , we confirmed reduced p54 nrb mRNA expression levels in MIA À/À mMSC (Fig. 4D ).
Along with Sox6 (Lefebvre et al., 1998 , p54 nrb has been described as a member of the Sox9 transcriptional complex (Hata et al., 2008) (Ionescu et al., 2001; Long et al., 2001) . Electrophoretic mobility shift assays (EMSA) revealed reduced binding of nuclear extracts from differentiated MIA À/À mMSC to AP1 and CREB consensus oligonucleotides compared to nuclear extracts from WT cells (Fig. 5A ). Further, we measured the activity of AP1 and CRE 
Discussion
MIA/CD-RAP is known to be coexpressed with Col2a1 at the beginning of chondroblast differentiation and its expression remains abundant throughout the entire chondrogenesis (Bosserhoff et al., 1997; Dietz and Sandell, 1996; Xie et al., 2000) . MIA/CD-RAP expression correlates also with the major cartilage component aggrecan (Onoue et al., 2011) . These findings qualify MIA/CD-RAP as a marker for chondrocyte differentiation (Bosserhoff and Buettner, 2003) . Interestingly, MIA À/À mice develop normally and show no striking abnormalities by light microscopic examinations but minor changes in ultrastructure of the cartilage extracellular matrix (Moser et al., 2002) . In this study we took a closer look on the process of endochondral ossification of the embryonic growth plate, since we assume redundant mechanism which compensation MIA/CD-RAP loss. In this study we discovered an increased zone of Col2a1-and Sox9-positive proliferating chondrocytes at day 15.5 of embryogenesis together with a diminished zone of Col10a1 expressing hypertrophic chondrocytes. Enhanced Sox9 mRNA expression levels could also be confirmed in vitro, together with enhanced Sox6 mRNA expression levels in murine mesenchymal stem cells derived from MIA À/À mice.
It is already known that Sox9 maintains proliferating chondrocytes in proliferation and inhibits transition to hypertrophic chondrocytes (Akiyama et al., 2002) , explaining the reduced zone of hypertrophic chondrocytes at day 15.5 of embryonic development. This is mediated by the inhibition of the main regulator of hypertrophic differentiation Runx2 (Inada et al., 1999; Kim et al., 1999; Takeda et al., 2001) . Runx2 initiates and mediates the entire process of hypertrophic differentiation of chondrocytes (Smith et al., 2005; Stricker et al., 2002) by transcription of genes important for this process, like MMP-13 (Collagenase-3) (Jimenez et al., 1999) und Col10a1 (Enomoto et al., 2000; Higashikawa et al., 2009; Zheng et al., 2003) . Since we found no alteration in Runx2 mRNA levels, it is likely that Sox9 inhibits Runx2 through direct interaction (Zhou et al., 2006) . Another way how enhanced proliferation is mediated by Sox9 and Sox6 in MIA À/À mice is the regulation of PTHrP expression. PTHrP is known to enhance proliferation and inhibits hypertrophic differentiation of chondrocytes (Karaplis et al., 1994; Lanske et al., 1996; Weir et al., 1996) in a well studied negative feedback loop with Ihh Vortkamp et al., 1996) . It was shown that Sox9 together with Sox6 activate PTHrP promoter activity (Amano et al., 2009) , hence an involvement of the PTHrP/Ihh feedback loop is likely. It is known that PTHrP delays hypertrophic differentiation via inhibition of Runx2 expression (Guo et al., 2006; Iwamoto et al., 2003; Li et al., 2004 (Beier et al., 2001; Beier and LuValle, 2002) . Cyclin D1 is a positive regulator of progression through the G1 phase, and Cyclin A, enhances progression through later stages of the cell cycle (Beier et al., 1999) . Furthermore, PTHrP enhances both the rate and extent of chondrocyte proliferation in part through suppression of the cyclindependent kinase inhibitor p57 expression (MacLean et al., 2004; Zhang et al., 1997) . In summary, our finding that the zone of proliferating chondrocytes is increased and hypertrophic differentiation of chondrocytes is delayed in the growth plate of MIA À/À mice, emphasized our previous study in which we demonstrated enhanced proliferation in MIA À/À mMSC and chondrocytes (Schmid et al., 2010) .
Although Ap-2a is known to act as a negative regulator of chondrocyte differentiation, Ap-2a has also been shown to maintain Sox9 mRNA expression (Huang et al., 2004 (Hata et al., 2008) . Although a direct interaction of Sox6 with Sox9 has not been shown yet (Lefebvre et al., 1998; Lefebvre, 2002) , Sox6 is besides p54 nrb also part of the Sox9 transcriptional complex, which enhances Sox9 mediated transcription (Lefebvre et al., 1998 ). Since we showed reduced p54 nrb expression in MIA À/À specimen in a previous study (Schmid et (Ionescu et al., 2001; Long et al., 2001) . In fact, AP1 and CREB activity were reduced in MIA À/À mMSC. CREB null mice are smaller than their littermates and die immediately after birth from respiratory distress (Rudolph et al., 1998) , a phenotype similar to that of Sox9 (Bi et al., 2001 ), L-Sox5 and Sox6 (Smits et al., 2001 ) and Runx2 knockout mice (Komori et al., 1997; Otto et al., 1997) . Expression of a potent dominant negative CREB inhibitor in growth plate chondrocytes of transgenic mice also leads to short-limbed dwarfism because of reduced chondrocyte proliferation (Long et al., 2001) . Another study emphasized the role of CREB during endochondral bone formation, since inhibition of CREB function led to a decrease in chondrocyte proliferation and an increase in hypertrophic maturation (Ionescu et al., 2001) similar to the phenotype observed in PTHrP-knockout mice (Karaplis et al., 1994) . PTHrP mediates CREB phosphorylation and activation through activation of PKA and to a lesser extent through PKC. Induction of PTHrP-dependent AP1 DNA binding activity is mediated by induction of c-Fos protein expression via activation of PKA (Ionescu et al., 2001) . It has been shown that phosphorylation of CREB, by PTHrP activated PKA, inhibits Runx2 expression at both mRNA and protein levels, what leads to inhibition of hypertrophic differentiation (Ionescu et al., 2001; Li et al., 2004) . PTHrP-dependent activation of AP1 signaling was also been shown to inhibit collagen type X expression, a marker for chondrocyte hypertrophy (Ionescu et al., 2001) . In summary, reduction of CREB and AP1 activity in MIA À/À endochondral ossification may facilitate enhanced hypertrophic differentiation at day 16.5 of bone development via activation of Runx2 expression in MIA À/À mice. Since CREB also activates Cyclin D1 promoter activity and expression (Beier et al., 2001; Beier and LuValle, 2002; Ionescu et al., 2001) as well as Cyclin A promoter activity (Beier and LuValle, 2002) 
Conclusion
In conclusion, we uncovered delayed hypertrophic differentiation of chondrocytes in the growth plate of MIA À/À mice modulated by enhanced Sox9 and AP-2a expression. Interestingly, inhibited CRE and AP1 activity was revealed as one mechanism to rescue terminal differentiation of chondrocytes in MIA À/À mice. We therefore suggest a multistep process which provides the redundant regulation in MIA À/À endochondral bone development leading to a normal adult phenotype.
Experimental procedures

Mice
Transgenic animals were generated as described previously (Moser et al., 2002) . C57Bl/6 control and MIA/CD-RAP-knockout mice were bred under specified pathogen-free conditions at 26°C, 70% relative humidity, and a 12-h light/ 12-h dark cycle at the University of Regensburg. They were fed with a breeding/maintenance diet (Altromin GmbH, Lage, Germany) and water ad libitum. The mice were randomly housed in polypropylene cages with sawdust bedding. The cages were sanitised twice weekly. Embryos were harvested on day 14.5, 15.5 and 16.5 days post coitum (dpc), whereas day 0.5 was on the day of detection of the vaginal plug. Littermates gained from heterozygous breeding were studied. The number of analyzed litters per developmental stage and the number of analyzed WT and MIA À/À embryos per litter is shown in Supplementary Table S1 . For PCR genotyping, whole genomic DNA extracts were isolated from tail biopsies using the QIAamp DNA Mini Kit (Qiagen, Hilden, Germany) as described by the manufacturer. Mia1 genotyping was performed using a PTC-200 Thermo Cycler (MJ Research, Waltham, MA, USA). A volume of 5 ll genomic DNA template, 0.5 ll of forward and reverse primers (20 lM), 5 ll PCR reaction buffer (10·), 0.5 ll dNTP mix (each 10 mM) and 0.5 ll Taq DNA polymerase in a total of 50 lL were applied in the following PCR program: 5 min at 95°C (initial denaturation); 30 s at 94°C (denaturation); 30 s at 58°C (annealing), 30 s at 72°C (elongation), repeated for 36 times. PCR products were evaluated by gel electrophoresis using a 1.5% agarose gel. Each genotype analysis was performed at least twice. All primers used are listed in Table 1 . Animal care and all experimental procedures were carried out in accordance with guidelines of the German law governing animal care.
In situ hybridization
For in situ hybridization of paraffin sections, digoxigeninlabelled mouse antisense RNA probes specific for Col2a1, Col10a1 and Sox9 mRNA were generated by reverse transcription. We used a 387 bp fragment of mouse Col2a1 cDNA, a 425 bp fragment of mouse Col10a1 cDNA, and a 255 bp fragment of mouse Sox9 cDNA. The vectors linearized with EcoRI BamHI (Col10a1) or HindIII (Sox9) were reverse transcribed using T3 RNA polymerase (Col2a1), or T7 RNA polymerase (Col10a1, Sox9) with digoxigenin-labeled dNTPs (Roche, Mannheim, Germany) for antisense RNA probes. RNA probes for mouse Col2a1 and Col10a1 were prepared from the 3 0 coding region (Schmidl et al., 2006) . The specificity of the probe for mouse Sox9 is described by (Zhao et al., 1997) . All probes were kindly provided by Klaus von der Mark (University of Erlangen-Nuernberg, Erlangen, Germany). Hind limbs from C57BL/6 and MIA À/À mouse embryos (at indicated embryonic stage) were fixed in 4% paraformaldehyde-PBS for 3 days, embedded in paraffin, and cut into 2 lm thick serial sections. Sections were analyzed by in situ hybridization as described previously (Schmidl et al., 2006) . The signals were detected with anti-digoxigenin-alkaline phosphatase antibody and BM Purple according to the manufacturer's descriptions (Roche). Sections were mounted with coverslips in Kaiser's glycerol gelatin (Merck, Darmstadt, Germany) and photographed with a Zeiss Axiovert200 microscope (Carl Zeiss, Jena, Germany). The length of the stained gene expression area was quantified using the AxioVision software (Zeiss) and was referred to total femur length. Staining intensity was not evaluated.
Cell isolation and cell culture of primary murine mesenchymal stem cells (MSCs)
Murine MSC were isolated and cultured as previously described (Schmid et al., 2010) . All experiments were performed at passages three to six. Multiple independent WT and MIA À/À mMSC lots were used. We analyzed five different lots of WT mMSC and six different lots of MIA À/À mMSC.
Each lot is established from at least 4 WT and MIA À/À mice, respectively.
Differentiation
For analysis of chondrogenesis, murine MSC differentiation was performed in two dimensional (2D) cultures. Differentiation was induced by incubation with TGF-b3. For this procedure, cells were cultured in induction medium including DMEM (PAA Laboratories Inc., Dartmouth, NH, USA), high glucose (Sigma-Aldrich Corp., St. Louis, MO, USA), 0.4% MEM Vitamins (Life Technologies Inc., Carlsbad, CA, USA), penicillin (100 U/ml), streptomycin (10 lg/ml) (both PAA), Amphotericin B (500 ng/ml), 0.1 lM dexamethasone, 1 mM sodium pyruvate, 0.17 mM ascorbic acid-2-phosphate, 0.35 mM proline (all Sigma), insulin (5 lg/ml), transferring (5 lg), selenious acid (5 ng) (ITS Premix; Becton Dickinson Biosciences, San Jose, CA, USA) and 10 ng/ml human TGF-b3 (HumanZyme Inc., Chicago, IL, USA). Each experiment was conducted with at least five different lots. Cells were harvested for isolation of RNA and protein.
5.5.
Nucleofection with plasmid DNA Nucleofection of mMSC was performed using the Human MSC Nucleofector Kit from Lonza (Basel, Switzerland) as described before (Schmid et al., 2010) . The pCMV-SPORT6-hp54 nrb plasmid (ImaGenes, Berlin, Germany, BC028299) under the regulation of a cytomegalovirus (CMV) enhancer/ promoter element and as a control the empty expression construct pCMX-PL1 were nucleofected.
RNA isolation and reverse transcription-PCR
Total RNA was isolated from cultured cells using the e.Z.N.A.Ò MicroEluteÒ Total RNA Kit (Omega Bio-Tek, Norcross, GA, USA) as described by the manufacturer. RNA concentration and purity was measured using a NanoDrop device (peqlab Biotechnologie GmbH, Erlangen, Germany). Complementary DNA (cDNA) was generated by reverse transcription of 500 ng total RNA as described previously (Schiffner et al., 2011) . The quality of complementary DNA was controlled and normalized by quantitative real-time polymerase chain reaction (qRT-PCR) amplification of the house keeping gene b-actin.
5.7.
Quantitative real-time PCR
Quantitative real-time PCR (qRT-PCR) analysis for murine b-actin, p54 nrb , Runx2, Sox6, Sox9, Tfap2a and Tfap2e was performed on a LightCycler 480 system (Roche) as described elsewhere (Canady et al., 2013) . Annealing and acquisition temperatures were optimized for each primer set. The PCR product was evaluated by melting-curve analysis according to the manufacturer's instructions and by agarose gel electrophoresis. Each analysis was performed at least in duplicate. The expression ratios of the analyzed genes were calculated using an internal control standard curve of b-actin levels. Primers used for PCR were obtained from Sigma and are shown in Table 2 . were seeded into 6-well plates and transfected with 0.5 lg plasmid DNA using the Lipofectamine Plus method (Life Technologies Inc.) according to the manufacturer's instructions. Murine MSCs were cultured in induction medium (see above) including 10 ng/mL human TGF-b3 (HumanZyme Inc.) to induce chondrogenic differentiation. Cells were lysed at 24 h after transfection and luciferase activity in the lysate was quantified with a luminometer using a Dual-Luciferase Reporter Assay System (Promega, Mannheim, Germany). Transfection efficiency was normalized according to the Renilla luciferase activity produced by cotransfecting 0.1 lg of the plasmid pRL-TK (Promega). Basal activity resulting from the pGL2basic vector was set to 1. All transfections were repeated four times.
Luciferase reporter constructs
For transient transfection, the pAP1-Luc Reporter Vector (AP1Luc) containing seven repeats of the AP1 Enhancer Elements (TGACTAA) 7 and the pCRE-Luc Vector (CRELuc) containing four CRE Enhancer Elements (AGCCTGACGTCAGAG) 4 was purchased from the PathDetectÒ in vivo Signal Transduction Pathway cis-Reporting System (Agilent Technologies Inc., Santa Clara, CA, USA).
Preparation of nuclear extracts
Nuclear extracts were prepared from cultured cells by the method of (Dignam et al., 1983) . For isolation of nuclear extracts, murine mesenchymal stem cells were harvested after differentiation in induction medium (see above).
Electrophoretic mobility shift assay (EMSA)
Pre-annealed double-stranded transcription factor oligonucleotides containing the consensus DNA binding site for the transcription factor AP1 and CREB (Table 3) were purchased from Agilent Technologies Inc. (Santa Clara, CA, USA). The fragments were end-labeled, and EMSA was performed as described previously (Wenke et al., 2009 ).
Statistical analysis
The mean and SD values were calculated from independent experiments, and the graphs were constructed with the GraphPad Prism software. Statistical significance between two groups was determined by using the Student's t-test. Software used was GraphPad PrismÒ 4.03 (GraphPad Software Inc., San Diego, USA). Statistical significance was analyzed on data from at least three independent experiments. A p-value <0.05 was considered statistically significant (n.s., not significant; * p < 0.05, ** p < 0.01, *** p < 0.001). 
